11.04.2022
Outsourced Pharma Capacity Update
Did you miss the large molecule Outsourced Pharma Capacity Update last month? Download the ondemand presentation to learn more...
News & Insights
Emergent CDMO News, Insights & Events
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
11.02.2022
The Demand for Nanoparticles in Drug Formulation is Rising
Demand for nanoparticles in the biopharmaceutical industry is on the rise. Production of these tiny particles, which can protect...
10.27.2022
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions
SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...
10.04.2022
Focus on Fill and Finish
Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...
09.01.2022
EXECUTIVE INTERVIEW – Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics
For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...
08.17.2022
How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines
Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...